[PDF] Top 20 Rev. Bras. Reumatol. vol.51 número5 en v51n5a11
Has 10000 "Rev. Bras. Reumatol. vol.51 número5 en v51n5a11" found on our website. Below are the top 20 most common "Rev. Bras. Reumatol. vol.51 número5 en v51n5a11".
Rev. Bras. Reumatol. vol.51 número5 en v51n5a11
... The author reports a case of septic arthritis due to Streptococcus bovis after several episodes of joint effusion treated with hyaluronic acid (Hylan G-F 20) and methylprednisolone a[r] ... See full document
5
Rev. Bras. Reumatol. vol.51 número4 en v51n4a01
... 5. Skare TL, Nakano I, Escuissiato DL, Batistetti, R, Rodrigues TO, Silva MB. Alterações de tomograia pulmonar de alta resolução em pacientes com artrite reumatoide e suas associações com variáveis clínicas, demográicas, ... See full document
3
Rev. Bras. Reumatol. vol.51 número6 en v51n6a08
... All other identifi ed studies were performed with patients in their natural environments. One of them compared the perception of the meteorological factors infl uencing OA pain among downtown Chicago’s residents, whose ... See full document
8
Rev. Bras. Reumatol. vol.51 número6 en v51n6a09
... to en- hance rapidly and intensely after the intravenous administration of gadolinium-based contrast material, unlike joint effusion, which does not enhance in the early ... See full document
8
Rev. Bras. Reumatol. vol.51 número6 en v51n6a10
... The interest in the reported case is due to the diagnostic approach to tuberculosis – a highly prevalent pathology among us – in a female patient with SLE, a disease that predisposes [r] ... See full document
4
Rev. Bras. Reumatol. vol.51 número6 en v51n6a11
... Therefore, patients pre- senting clinical signs and symptoms resulting from infi ltrative processes of soft tissues, joints, periarticular tissues, and bones should be submitted to an [r] ... See full document
5
Rev. Bras. Reumatol. vol.51 número6 en v51n6a12
... The clinical fi ndings and thrombotic vasculopathy found on the histopathological study, in association with the high anticardiolipin titers and the presence of lupus anticoagulant ant[r] ... See full document
5
Rev. Bras. Reumatol. vol.51 número6 en v51n6a13
... Most interviewees (19%) pointed out that the limitation of bioequivalence tests is the major problem; 18% pointed out the safety matter; 16% indicated the establishment of bioeffi cac[r] ... See full document
6
Rev. Bras. Reumatol. vol.51 número6 en v51n6a14
... The relevant conclusion of that study is that almost two thirds of those patients (64.7%) had an increase in total cholesterol over time, and that the variation of its levels was dire[r] ... See full document
2
Rev. Bras. Reumatol. vol.51 número4 en v51n4a02
... This study aimed at assessing the applicability of the pain assessment instruments in each of the following hospital set- tings: orthopedic emergency unit; Rheumatology outpatient clin[r] ... See full document
6
Rev. Bras. Reumatol. vol.51 número6 en v51n6a06
... Objectives: This study aimed to investigate the genetic infl uence of the T102C polymorphism of the 2A serotonin receptor gene (HTR2A) and its interaction with environmental aspects, s[r] ... See full document
9
Rev. Bras. Reumatol. vol.51 número4 en v51n4a03
... 6. Reuters VS, Buescu A, Reis FA, Almeida CP, Teixeira PF, Costa AJ et al. Clinical and muscular evaluation in patients with subclinical hypothyroidism. Arq Bras Endocrinol Metabol 2006; 50(3):523-31. 7. Ranque B, ... See full document
3
Rev. Bras. Reumatol. vol.51 número4 en v51n4a04
... The study comprised SSc patients followed up at the Service of Rheumatology of the Hospital de Clínicas of the UFPR. The study inclusion period was from September 2007 to September 20[r] ... See full document
7
Rev. Bras. Reumatol. vol.51 número4 en v51n4a05
... In the sample studied, the age of RA onset ranged from 22 to 73 years (mean, 43.9 ± 11.0 years), 24/67 (35.8%) patients were smokers and ex-smokers, and 43/67 (64.1%) had no tobacco exposure. Rheumatoid nodules were ... See full document
8
Rev. Bras. Reumatol. vol.51 número4 en v51n4a07
... its own. Thus, there are two possibilities: a) the activating receptor recognizes its ligand (not generating a signal) and the inhibitory receptor does not recognize the ligand (not g[r] ... See full document
9
Rev. Bras. Reumatol. vol.51 número4 en v51n4a08
... 80 In a summary of the results of four clinical trials of strontium ranelate, three for treatment of osteoporosis 82-86 and one for prevention, 85 2 g/day of strontium ranelate result[r] ... See full document
11
Rev. Bras. Reumatol. vol.51 número4 en v51n4a09
... 11 The infl uence of a 3-month chloroquine treatment on lipid metabolism was assessed in 34 SLE patients; total cholesterol, LDL cholesterol and tri- glycerides levels were signifi ca[r] ... See full document
4
Rev. Bras. Reumatol. vol.51 número4 en v51n4a10
... Poncet’s disease is a rare clinical condition, characterized by polyarticular impairment in a patient diagnosed with tuberculosis, with no evidence of direct bacillary invasion of the j[r] ... See full document
4
Rev. Bras. Reumatol. vol.51 número4 en v51n4a11
... Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japa[r] ... See full document
4
Rev. Bras. Reumatol. vol.51 número6 en v51n6a07
... Data were collected from the electronic medical records of the SARAH network. Patients with RA and OA undergoing hip or knee arthroplasties were selected through automatic search. The[r] ... See full document
8
temas relacionados